β-lactam-cannabinoid conjugate molecules
US12257307B2 · kind B2 · utility
0Cited by
16References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 24, 2020 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Jun 22, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D501/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides multifunctional conjugate molecules in which at least one β-lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the β-lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.